ALX Oncology Holdings Inc (ALXO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ALXO Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-10-20 2021-10-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
14,471 -3.1%
54.17
783,848 USD 		14,471 -3.1% 54.17 783,848 USD
2021-10-20 2021-10-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
2,229 -0.5%
55.12
122,866 USD 		2,229 -0.5% 55.12 122,866 USD
2021-10-20 2021-10-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
14,471 -3.1%
54.17
783,848 USD 		14,471 -3.1% 54.17 783,848 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
189 -2.0%
59.06
11,163 USD 		189 -2.0% 59.06 11,163 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
438 -4.4%
58.30
25,537 USD 		438 -4.4% 58.30 25,537 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
411 -4.0%
57.54
23,648 USD 		411 -4.0% 57.54 23,648 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,437 -12.2%
56.09
80,603 USD 		1,437 -12.2% 56.09 80,603 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,903 -13.9%
55.15
104,958 USD 		1,903 -13.9% 55.15 104,958 USD
2021-10-19 2021-10-18 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
2,851 -17.2%
54.33
154,884 USD 		2,851 -17.2% 54.33 154,884 USD
2021-10-12 2021-10-11 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
2,439 -1.6%
61.36
149,646 USD 		2,439 -1.6% 61.36 149,646 USD
2021-10-12 2021-10-11 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
4,948 -3.2%
60.79
300,776 USD 		4,948 -3.2% 60.79 300,776 USD
2021-09-17 2021-09-17 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,100 -10.5%
81.19
89,309 USD 		1,100 -10.5% 81.19 89,309 USD
2021-09-17 2021-09-17 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
273 -2.6%
80.22
21,901 USD 		273 -2.6% 80.22 21,901 USD
2021-09-17 2021-09-17 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,746 -14.0%
79.46
138,734 USD 		1,746 -14.0% 79.46 138,734 USD
2021-09-17 2021-09-17 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
7,199 -36.6%
78.61
565,922 USD 		7,199 -36.6% 78.61 565,922 USD
2021-09-17 2021-09-17 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,027 -5.0%
77.84
79,944 USD 		1,027 -5.0% 77.84 79,944 USD
2021-09-17 2021-09-16 PS Planned sale

GARCIA PETER S

Chief Financial Officer

Officer
1,426 -13.3%
80.43
114,695 USD 		1,426 -13.3% 80.43 114,695 USD
2021-09-13 2021-09-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,458 -0.9%
78.31
114,183 USD 		1,458 -0.9% 78.31 114,183 USD
2021-09-13 2021-09-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
5,029 -3.1%
77.69
390,682 USD 		5,029 -3.1% 77.69 390,682 USD
2021-09-13 2021-09-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
900 -0.5%
76.45
68,806 USD 		900 -0.5% 76.45 68,806 USD
2021-07-20 2021-07-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
5,900 -1.2%
55.08
324,984 USD 		5,900 -1.2% 55.08 324,984 USD
2021-07-20 2021-07-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
9,500 -1.9%
54.37
516,553 USD 		9,500 -1.9% 54.37 516,553 USD
2021-07-20 2021-07-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
1,300 -0.3%
53.62
69,708 USD 		1,300 -0.3% 53.62 69,708 USD
2021-06-22 2021-06-21 PS Planned sale

Pons Jaume

President & CEO

Executive Director
10,353 -2.0%
58.92
609,976 USD 		10,353 -2.0% 58.92 609,976 USD
2021-06-22 2021-06-21 PS Planned sale

Pons Jaume

President & CEO

Executive Director
6,347 -1.2%
58.06
368,504 USD 		6,347 -1.2% 58.06 368,504 USD
2021-06-14 2021-06-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,794 -1.0%
61.53
110,385 USD 		1,794 -1.0% 61.53 110,385 USD
2021-06-14 2021-06-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
4,405 -2.4%
60.90
268,274 USD 		4,405 -2.4% 60.90 268,274 USD
2021-06-14 2021-06-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,188 -0.6%
59.80
71,038 USD 		1,188 -0.6% 59.80 71,038 USD
2021-05-20 2021-05-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
979 -0.2%
56.71
55,515 USD 		979 -0.2% 56.71 55,515 USD
2021-05-20 2021-05-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
15,221 -2.8%
55.69
847,659 USD 		15,221 -2.8% 55.69 847,659 USD
2021-05-20 2021-05-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
500 -0.1%
54.20
27,102 USD 		500 -0.1% 54.20 27,102 USD
2021-05-11 2021-05-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
73 -0.0%
64.56
4,713 USD 		73 -0.0% 64.56 4,713 USD
2021-05-11 2021-05-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
956 -0.5%
62.79
60,026 USD 		956 -0.5% 62.79 60,026 USD
2021-05-11 2021-05-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
4,433 -2.3%
62.12
275,378 USD 		4,433 -2.3% 62.12 275,378 USD
2021-05-11 2021-05-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,925 -1.0%
61.12
117,654 USD 		1,925 -1.0% 61.12 117,654 USD
2021-04-21 2021-04-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
837 -0.2%
60.48
50,618 USD 		837 -0.2% 60.48 50,618 USD
2021-04-21 2021-04-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
663 -0.1%
59.52
39,460 USD 		663 -0.1% 59.52 39,460 USD
2021-04-21 2021-04-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
2,914 -0.5%
58.36
170,054 USD 		2,914 -0.5% 58.36 170,054 USD
2021-04-21 2021-04-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
6,956 -1.3%
57.73
401,568 USD 		6,956 -1.3% 57.73 401,568 USD
2021-04-21 2021-04-19 PS Planned sale

Pons Jaume

President & CEO

Executive Director
5,330 -0.9%
56.42
300,733 USD 		5,330 -0.9% 56.42 300,733 USD
2021-04-13 2021-04-12 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
284 -0.1%
63.51
18,037 USD 		284 -0.1% 63.51 18,037 USD
2021-04-13 2021-04-12 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
259 -0.1%
61.59
15,953 USD 		259 -0.1% 61.59 15,953 USD
2021-04-13 2021-04-12 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
2,941 -1.5%
60.29
177,299 USD 		2,941 -1.5% 60.29 177,299 USD
2021-04-13 2021-04-12 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,000 -0.5%
59.15
59,148 USD 		1,000 -0.5% 59.15 59,148 USD
2021-04-13 2021-04-12 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
2,903 -1.4%
58.06
168,541 USD 		2,903 -1.4% 58.06 168,541 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
600 -0.1%
70.12
42,075 USD 		600 -0.1% 70.12 42,075 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
9,200 -1.6%
69.77
641,857 USD 		9,200 -1.6% 69.77 641,857 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
2,700 -0.5%
68.27
184,329 USD 		2,700 -0.5% 68.27 184,329 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
1,500 -0.3%
67.18
100,773 USD 		1,500 -0.3% 67.18 100,773 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
600 -0.1%
66.33
39,795 USD 		600 -0.1% 66.33 39,795 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
900 -0.2%
64.98
58,486 USD 		900 -0.2% 64.98 58,486 USD
2021-03-24 2021-03-22 PS Planned sale

Pons Jaume

President and CEO

Executive Director
1,200 -0.2%
63.79
76,545 USD 		1,200 -0.2% 63.79 76,545 USD
2021-03-12 2021-03-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
100 -0.0%
76.69
7,669 USD 		100 -0.0% 76.69 7,669 USD
2021-03-12 2021-03-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,146 -0.6%
75.20
86,177 USD 		1,146 -0.6% 75.20 86,177 USD
2021-03-12 2021-03-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
4,844 -2.3%
74.35
360,151 USD 		4,844 -2.3% 74.35 360,151 USD
2021-03-12 2021-03-10 PS Planned sale

Randolph Sophia

Chief Medical Officer

Executive Director
1,297 -0.6%
73.38
95,177 USD 		1,297 -0.6% 73.38 95,177 USD
2020-12-15 2020-12-14 B Purchase

Graham G. Walmsley

Non-Executive Director
20,000 +2.1%
76.00
1,520,000 USD 		20,000 +2.1% 76.00 1,520,000 USD
2020-07-22 2020-07-21 B Purchase

LSV Associates, LLC

Major owner
22,000 +inf%
19.00
418,000 USD 		22,000 +inf% 19.00 418,000 USD
2020-07-22 2020-07-21 B Purchase

LSV Associates, LLC

Major owner
378,000 +inf%
19.00
7,182,000 USD 		378,000 +inf% 19.00 7,182,000 USD
2020-07-21 2020-07-21 B Purchase

Adelman Robert J

See Remarks

Major owner
3,000 +3.1%
19.00
57,000 USD 		3,000 +3.1% 19.00 57,000 USD
2020-07-21 2020-07-21 B Purchase

Adelman Robert J

See Remarks

Major owner
850,000 +19.2%
19.00
16,150,000 USD 		850,000 +19.2% 19.00 16,150,000 USD
2020-07-21 2020-07-21 B Purchase

Graham G. Walmsley

Non-Executive Director
975,000 +inf%
19.00
18,525,000 USD 		975,000 +inf% 19.00 18,525,000 USD
2020-07-21 2020-07-21 B Purchase

GOODMAN COREY S

Executive Chairman

Non-Executive Director Major owner
850,000 +inf%
19.00
16,150,000 USD 		850,000 +inf% 19.00 16,150,000 USD
2020-07-21 2020-07-21 B Purchase

Vivo Capital IX, LLC

Major owner
185,526 +inf%
19.00
3,524,994 USD 		185,526 +inf% 19.00 3,524,994 USD
2020-07-21 2020-07-21 B Purchase

Lettmann Jason

Non-Executive Director Major owner
22,000 +inf%
19.00
418,000 USD 		22,000 +inf% 19.00 418,000 USD
2020-07-21 2020-07-21 B Purchase

Lettmann Jason

Non-Executive Director Major owner
378,000 +inf%
19.00
7,182,000 USD 		378,000 +inf% 19.00 7,182,000 USD
2020-07-21 2020-07-21 B Purchase

GARCIA PETER S

Chief Financial Officer

Officer
3,000 +inf%
19.00
57,000 USD 		3,000 +inf% 19.00 57,000 USD
2020-07-21 2020-07-21 B Purchase

Pietzke Steffen

VP Fin & Chief Acct Officer

Officer
3,000 +inf%
19.00
57,000 USD 		3,000 +inf% 19.00 57,000 USD
2020-07-21 2020-07-21 B Purchase

Vivo Capital IX, LLC

Major owner
789,474 +inf%
19.00
15,000,006 USD 		789,474 +inf% 19.00 15,000,006 USD
2020-07-21 2020-07-21 B Purchase

Hemrajani Rekha

Non-Executive Director
3,000 +inf%
19.00
57,000 USD 		3,000 +inf% 19.00 57,000 USD